Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy

Du SH, Li Z, Chen C, Tan WK, Chi Z, Kwang TW, Xu XH, Wang S

PLOS ONE 2016, 11: e0161820

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161820

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis

Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells

B2 miceta-roglobulin knockout K562 cell-based artificial antigen presenting cells for ex vivo expansion of T lymphocytes

Zha S, Li Z, Chen C, Du Z, Tay JC, Wang S

Immunotherapy 2019, 11: 967

https://www.futuremedicine.com/doi/abs/10.2217/imt-2018-0211